---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-084991"
form_type: "8-K"
ticker: null
cik: "0001673772"
company_name: "RAPT Therapeutics, Inc."
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T19:05:25.407912+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# RAPT Therapeutics cuts 40% of workforce (47 employees) to conserve cash, expects $0.9M charge

## Summary
- Board approved workforce reduction of 47 people, representing ~40% of total headcount.
- Company expects ~$0.9 million in restructuring charges from severance, benefits, and related costs.
- Majority of cash payments and execution expected by end of Q3 2024.
- Severance benefits contingent on affected employees signing general release of claims.

## SEC filing metadata
- accession: 0000950170-24-084991
- form_type: 8-K
- cik: 0001673772
- company_name: RAPT Therapeutics, Inc.
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1673772/000095017024084991/0000950170-24-084991-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1673772/000095017024084991/rapt-20240716.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-084991
- JSON: https://secwatch.observer/filing/0000950170-24-084991.json
- Plain text: https://secwatch.observer/filing/0000950170-24-084991.txt

## Key facts
- Restructurings & Charges
  RAPT Therapeutics, Inc. announced a restructuring with charges of approximately $0.9 million (47 people, or approximately 40% of the Company's existing headcount).
  - Type: restructuring
  - Charge: approximately $0.9 million
  - Headcount: 47 people, or approximately 40% of the Company's existing headcount
  source text: for severance benefits is contingent upon such employee’s execution of a general release of claims against the Company. The Company estimates that it will incur approximately $0.9 million in restructuring charges in connection with the workforce reduction, consisting of cash-based expenses related to employee severance payments, benefits and related costs. The
  evidence_url: https://www.sec.gov/Archives/edgar/data/1673772/000095017024084991/0000950170-24-084991-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.